Cefuroxime IV is NOT recommended for typhoid fever
Cefuroxime is not included in any current guideline recommendations for the treatment of typhoid fever, and you should use ceftriaxone (a third-generation cephalosporin) instead if a cephalosporin is indicated. 1
Why Cefuroxime Should Not Be Used
Guideline Recommendations Specify Other Agents
The WHO guidelines for typhoid fever explicitly recommend:
- First-line treatment: Fluoroquinolones (ciprofloxacin, gatifloxacin, ofloxacin) for fully sensitive strains 1
- Second-line treatment (for poor response or resistance): Third-generation cephalosporins such as ceftriaxone or azithromycin 1
- For quinolone-resistant strains: Azithromycin or ceftriaxone as primary options 1
Cefuroxime is a second-generation cephalosporin and is conspicuously absent from all guideline recommendations. 1
Limited and Outdated Evidence for Cefuroxime
The only available evidence for cefuroxime in typhoid fever is:
- A single small study from 1996 using oral cefuroxime axetil (not IV cefuroxime) in 30 patients, which is over 25 years old and predates current resistance patterns 2
- The FDA label for IV cefuroxime does not list typhoid fever as an approved indication 3
Third-Generation Cephalosporins Are Superior
Ceftriaxone specifically has demonstrated effectiveness in treating enteric fever with:
- Low rates of clinical failure when compared to azithromycin (RR 0.42,95% CI 0.11 to 1.57) 4
- Shorter time to defervescence compared to azithromycin (mean difference -0.52 days) 4
- Effectiveness against multidrug-resistant and quinolone-resistant strains 1
What You Should Use Instead
For Uncomplicated Typhoid Fever:
- If fluoroquinolone-sensitive: Use a fluoroquinolone (ciprofloxacin, ofloxacin, or gatifloxacin) 1
- If fluoroquinolone-resistant or multidrug-resistant: Use ceftriaxone 2-4 g IV daily or azithromycin 1, 4
- If extensively drug-resistant (XDR): Ceftriaxone remains an option along with azithromycin 5
Dosing for Ceftriaxone:
- Adults: 2-4 g IV daily 4
- Children: 50-75 mg/kg/day IV (up to 4 g/day) 4
- Duration: Typically 10-14 days 4, 6
Critical Pitfalls to Avoid
Do not use cefixime (an oral third-generation cephalosporin) as a substitute for ceftriaxone in severely ill patients, as cefixime may have higher rates of clinical failure compared to fluoroquinolones (RR 13.39,95% CI 3.24 to 55.39) 4. Cefixime is reserved for less severe cases or step-down therapy 7, 6.
Always obtain blood cultures before starting antibiotics to confirm the diagnosis and guide antibiotic selection based on susceptibility patterns, as resistance patterns vary significantly by geographic region and are changing over time 8, 5, 6.
Consider local resistance patterns: In areas with high rates of nalidixic acid resistance, fluoroquinolones require much higher doses (10 times the usual MIC) and may not be effective 6. In such settings, ceftriaxone or azithromycin should be first-line 6.